LeadArt Biotechnologies

United States

10 - 50 employees

10 - 50 researchers

2 R&D centers

$2.5M - $5M in R&D spend

LeadArt Biotechnologies is a pioneering force in automating Chemoproteomics for drug discovery, especially targeting challenging and previously undruggable areas via its unique probe library.

Partnering Interests

Live Cell Protein-Ligand Data Collecting

Boosted by our advanced automated sample preparation station, we could collect and build a comprehensive live-cell protein/ligand interaction database in a few months across various cell lines. These "cellular SPR" data is invaluable in drug discovery processes.

Screening Assay

We built an extensive probe library with over 4,000 chemical probes, alongside an advanced automated sample preparation station. Our innovative HTS platform and ongoing initiative to create a comprehensive live-cell protein-probe/ligand interaction database, covering over 15,000 human proteins. We are seeking for partners in area of tailored drug screening assay or design of early-stage pipelines.

Our Team

Feng Ni